Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03269 |
| Species: | Homo sapiens |
| Position : | chr15:96725740-96737960 |
| Year: | 2018 |
| Title: | Tbx20 Is Required in Mid-Gestation Cardiomyocytes and Plays a Central Role in Atrial Development. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Congenital Heart Disease |
| PMID: | 29903739 |
| Tissue: | heart |
| Tissue Ontology ID: | UBERON:0000948 |
| Cell Source: | E11.5 Heart |
| Cell Type: | cardiomyocyte |
| Cell Ontology ID: | CL:0000746 |
| Experiment Type: | TF-binding/chromatin assay; Chromatin interaction assay; In vivo functional validation; Disease-associated enhancer analysis |
| High Throughput Method: | ChIP-seq; Hi-C |
| Low Throughput Method: | ChIP-qPCR/ChIP |
| Target gene : | NR2F2 |
| TF name : | TBX20 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| TBX20 | Hs_Heart_Development_WP1591_90186 | wikipathways | 28 |